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 15 
Advanced bioproduct synthesis via reductive metabolism requires coordinating carbons, ATP, and 16 
reducing agents, which are generated with varying efficiencies depending on metabolic pathways. 17 
Substrate mixtures with shortcut access concurrently to multiple pathways may optimally satisfy 18 
these biosynthetic requirements. However, native regulation favoring preferential utilization 19 
precludes cells from co-metabolizing multiple substrates. Here we explore mixed substrate 20 
metabolism and tailor pathway usage to synergistically stimulate carbon reduction. By controlled 21 
cofeeding of superior ATP- and NADPH-generators as “dopant” substrates to cells primarily 22 
utilizing inferior substrates, we circumvent catabolite repression and drive synergy in two 23 
divergent organisms. Glucose doping in Moorella thermoacetica stimulates CO2 reduction (2.3 24 
g/gcell/hr) into acetate by augmenting ATP synthesis via pyruvate kinase. Gluconate doping in 25 
Yarrowia lipolytica accelerates acetate-driven lipogenesis (0.046 g/gcell/hr) by obligatory NADPH 26 
synthesis through the pentose cycle. Together, synergistic cofeeding produces CO2-derived lipids 27 
with 38% energetic efficiency and demonstrates potential to convert CO2 into advanced 28 
bioproducts. 29 
  30 
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Introduction 31 
One of the greatest feats of metabolism is the ability to synthesize reduced compounds from input 32 
substrates with varying oxidation states. Using reductive metabolism, cells reassemble the output 33 
of substrate catabolism for energy-dense bioproduct synthesis1. This process is often implemented 34 
in both laboratory and industry with single organic carbon sources (e.g., sugars) as inputs due to 35 
simplicity2,3. Nonetheless, single substrates naturally impose stoichiometric constraints on 36 
available carbons, energy, and redox cofactors, leading to biosynthetic imbalance and suboptimal 37 
product yield. Thus, genetic rewiring of metabolic pathways is required to advantageously shift 38 
these stoichiometries4, which precludes wide application of non-model organisms that lack suitable 39 
genetic tools5. 40 
Substrate mixtures, on the other hand, present the potential to alleviate such stoichiometric 41 
constraints in reductive metabolism without genetic rewiring. Since each substrate has unique 42 
efficiencies for carbon, energy, and cofactor generation, varying the relative amounts of substrates 43 
in the mixture allows fine-tuning of carbon-to-energy-to-cofactor ratios. Furthermore, substrates 44 
with different entry points to metabolism alleviate protein burdens by providing the required 45 
components in fewer enzymatic steps. Nevertheless, mixed substrate metabolism is epitomized by 46 
sequential (e.g., diauxie) and hierarchical (yet simultaneous) utilization based on substrate 47 
preference6-8, reflecting the evolutionary fitness of cells in their native environments9. Despite the 48 
recent success of substrate mixture batch fermentation using limited substrate pairs (that do not 49 
trigger catabolite repression)10,11, genetic engineering12,13, and directed evolution14-16, the full 50 
mixture spectrum remains inaccessible and thus unexplored. 51 
Here we report a simple and universal solution to overcoming undesirable substrate preferences 52 
and improving carbon reduction in various organisms. We eliminate catabolite repression by 53 
controlling the continuous feed rate of preferred superior substrates to maintain negligible 54 
concentrations in systems dominated by inferior substrates. Using this method, we explored mixed 55 
substrate metabolism and therein observed enhanced metabolic productivity that exceeds the sum 56 
of individual-substrate productivities. 57 
This substrate cofeeding scheme was applied to two widely divergent organisms to optimize 58 
reductive metabolism of lipogenesis and acetogenesis. We cultured the oleaginous yeast Y. lipolytica 59 
on acetate and continuously fed limiting quantities of glucose, fructose, glycerol, or gluconate as 60 
“dopant substrates” to augment reductive metabolism. In this fed-batch setup, cells simultaneously 61 
consumed acetate and the supplemented substrate with acetate remaining as the primary carbon 62 
source. In particular, the rate of lipogenesis with gluconate doping was twice as fast as that of the 63 
acetate-only control. Tracing 13C from gluconate revealed that obligatory NADPH synthesis by 64 
recursive use of the oxidative pentose phosphate pathway (oxPPP) was responsible for the 65 
observed synergy with acetate. 66 
We then set out to source acetate via acetogenesis, a reductive metabolic process starting from CO2. 67 
Acetogenic bacterium M. thermoacetica simultaneously consumes CO2 and glucose with the latter 68 
providing both ATP and electrons (e–) necessary for CO2 fixation, cell maintenance, and growth17. 69 
However, tracing 13C-labeled glucose revealed that glucose metabolism dominated and e– 70 
generation was coupled to undesirable decarboxylation. To shift cellular metabolism towards 71 
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greater CO2 incorporation, we designed a chemostat that continuously supplied limiting glucose 72 
and ample H2. Under these conditions, CO2 reduction metabolism dominated, glucose primarily 73 
produced ATP sufficient for cell maintenance via pyruvate kinase, and carbon-free e– for net CO2 74 
reduction was supplied by H2. Importantly, with dopant substrate glucose, M. thermoacetica rapidly 75 
converted CO2 into acetate exclusively, serving as the ideal input for gluconate-doped lipogenesis. 76 
With the aforementioned synergy, we fixed CO2 at 2.3 g per g cell dry weight per hour (g gCDW–1 hr–77 
1), substantially faster than ~0.05 g gCDW–1 hr–1 of typical photosynthetic systems18. Using the 78 
resulting acetate, we produced lipids at 0.046 g gCDW–1 hr–1, a more than two-fold improvement 79 
over the previously optimized system (~0.02 g gCDW–1 hr–1)19. Coordinating the glucose-doped 80 
acetogenesis and gluconate-doped lipogenesis, we converted carbons in the most oxidized, 81 
undesirable state (CO2) to the reduced, energy-dense state (lipids) with 38% energetic efficiency. 82 
Through substrate cofeeding, we overcame the limitation of ATP- and NADPH-dependent biological 83 
carbon reduction, paving the path for CO2-derived advanced bioproduct synthesis. 84 
Accelerating lipogenesis from acetate by enhancing NADPH generation in Y. lipolytica 85 
Lipogenesis requires a balanced supply of acetyl-CoA, ATP, and NADPH at a ~1:1:2 ratio. Single 86 
substrates, such as glucose and acetate, can provide all three building blocks for lipids19-21. 87 
However, lipid synthesis from acetate, despite acetate’s direct contribution to acetyl-CoA and ATP, 88 
is slower compared to that from glucose22 (Fig. 1A). This is because in Y. lipolytica, NADPH 89 
generation is mainly through oxPPP, which takes a series of ATP-intensive reactions to arrive at 90 
starting from acetate23. 91 
We aimed to enhance acetate-to-lipid conversion by better supplying NADPH. Since glucose can 92 
flow more directly into oxPPP than acetate, we provided both acetate and glucose to a Y. lipolytica 93 
batch culture. Consistent with the widely accepted phenomenon of catabolite repression24, cells 94 
consumed glucose only at first (Supplementary Fig. 1). To overcome this selective preference (i.e., 95 
diauxie), we devised a fed-batch system, in which the same amount of glucose was instead 96 
continuously supplied over the course of fermentation to an acetate culture (Fig. 1B). The feed rate 97 
was kept slow to maintain negligible glucose concentrations in the reactor. In this setup, despite 98 
constant introduction of glucose, we observed steadily decreasing acetate and no glucose in the 99 
reactor, suggesting simultaneous consumption of the two carbon sources (Fig. 1C). Furthermore, 100 
the fed-batch cofeeding strategy enhanced both the growth and lipid production in Y. lipolytica 101 
significantly compared to the acetate-only control (Fig. 1D,E). 102 
Using the same fed-batch system, we also tested supplementing other substrates (fructose, glycerol, 103 
and gluconate) that enter metabolism near oxPPP as metabolic “dopants” to provide NADPH (Fig. 104 
2A). In all cases, we observed simultaneous consumption of acetate and the supplemented 105 
substrate (Supplementary Fig. 2). As with glucose, cell growth and lipid production were 106 
enhanced (Supplementary Fig. 3) despite the supplemental substrates constituting only small 107 
fractions of carbons (Fig. 2B). To distinguish whether the increase in lipid production was due to 108 
cellular metabolism enhancements or simply having more cells in the culture, we determined 109 
specific growth rates and productivities. Substrate doping nearly doubled both the specific growth 110 
rate (Fig. 2C) and the specific lipid productivity during nitrogen-replete growth phase (Fig. 2D). In 111 
nitrogen-depleted lipogenic phase, glucose, fructose, and glycerol cofeeding only modestly 112 
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enhanced specific productivity while gluconate cofeeding significantly outperformed all other 113 
conditions (Fig. 2E). 114 
Recursive NADPH generation via the pentose cycle 115 
To understand the mechanism of accelerated lipid production, we aimed to elucidate how 116 
continuous gluconate supplementation rewires metabolism. Tracing the carbons from [U-117 
13C6]gluconate by liquid chromatography-mass spectrometry (LC-MS), we observed that the 13C 118 
atoms were confined to the PPP and upper glycolysis (Fig. 3A and Supplementary Table 1). 119 
Gluconate enters metabolism as 6-phosphogluconate (6PG), which can only go in the oxidative 120 
direction through oxPPP because the combined thermodynamics of glucose-6-phosphate 121 
dehydrogenase and 6-phosphogluconolactonase (ΔG°’=–29 kJ/mol) strongly favors the flow of 6PG 122 
further into PPP25. This causes gluconate to obligatorily generate NADPH via 6PG dehydrogenase, 123 
which is likely responsible for the acceleration of lipogenesis. On the other hand, metabolites in the 124 
TCA cycle as well as fatty acids were completely unlabeled, indicating exclusive contribution of 125 
lipogenic acetyl-CoA and ATP from acetate (Fig. 3A and Supplementary Table 1). These labeling 126 
data suggested the partitioned usage of metabolism where acetate primarily provided acetyl-CoA 127 
and ATP while gluconate primarily provided NADPH to meet the metabolic demands of lipogenesis.  128 
To further validate the hypothesis that gluconate enhances lipogenesis through NADPH 129 
supplementation, we performed metabolic flux analysis using the labeling data, substrate uptake 130 
rates, and lipid production rate. The flux distribution that best fit all these measurements revealed a 131 
strong flux through the oxPPP NADPH-generating steps (Fig. 3B and Supplementary Table 2). 132 
Interestingly, phosphoglucose isomerase operated in the reverse direction converting fructose-6-133 
phosphate (F6P) to glucose-6-phosphate (G6P). The flux analysis also revealed that gluconeogenic, 134 
oxPPP, and non-oxPPP fluxes together form a metabolic cycle, which we termed the “pentose cycle” 135 
(Fig. 3B and Supplementary Table 2). Akin to the TCA cycle, the pentose cycle recursively 136 
oxidized the carbons from gluconate into CO2 while preserving the electrons as NADPH for 137 
lipogenesis, maximizing the dopant substrate’s role as a NADPH provider.  138 
Preferential use of glucose leads to excessive decarboxylation in CO2-fixing M. thermoacetica 139 
Acetogenesis is a reductive metabolic process that produces acetate from CO2. In acetogenic 140 
organisms, the reductive acetyl-CoA pathway incorporates CO2 as carbonyl and methyl components 141 
of the acetyl group26 (Fig. 4A). The methyl branch of this pathway requires ATP, which acetogens 142 
may recover by acetate production. This ATP conservation contributes to efficient autotrophic CO2 143 
fixation27, but autotrophic culture conditions, which derive energy solely from inorganic sources 144 
(e.g., oxidation of H2), results in slow metabolism and low culture density28,29. 145 
Since glycolysis effectively produces ATP and e– necessary for operating the reductive acetyl-CoA 146 
pathway, we co-fed CO2 and [U-13C6]glucose to M. thermoacetica and looked for signs of CO2 147 
incorporation. If acetate were the only product, we would expect up to 100% carbon yield, that is, 148 
three acetate molecules per glucose29. On the other hand, with potential other products (e.g., 149 
pyruvate) or biomass components (e.g., Ser/Gly, Asp, and Glu), net CO2 utilization becomes feasible 150 
as some pathways generate reducing agents without CO2 production or fix more CO2 than the 151 
amount produced (Supplementary Fig. 4). Since net CO2 utilization depends on the types and 152 
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fractions of fermentation products, we quantified the cell growth, the secreted molecules, and their 153 
carbon yields relative to glucose consumption (Fig. 4B). We observed the activity of the reductive 154 
acetyl-CoA pathway as the produced acetate accounted for 77% of glucose carbons, exceeding what 155 
is possible via glycolysis (67%). However, as glucose carbon consumption rate approximately 156 
matched the total carbon output rate of major products (i.e., biomass, acetate, and formate 157 
accounted for 93%), we did not observe net CO2 utilization. 158 
We hypothesized that our observed carbon yield was due to insufficient reducing agents available 159 
for new CO2 utilization and cells preferentially consuming glucose over CO2. To trace the fate of 13C-160 
glucose carbons and to visualize metabolic pathway usage, we measured 13C enrichment in cellular 161 
metabolites using LC-MS. Unlabeled CO2 was provided in the headspace and CO2 remained mostly 162 
unlabeled (Supplementary Fig. 5). The carbons of glycolytic intermediates were ≥90% labeled 163 
except for pyruvate, which was ~50% labeled (Fig. 4C, Supplementary Table 3). The lower 164 
labeling in pyruvate was due to reversible pyruvate:ferredoxin oxidoreductase (PFOR), which can 165 
form pyruvate by combining unlabeled CO2 and acetyl group derived from the reductive acetyl-CoA 166 
pathway. With phosphoenolpyruvate (PEP) remaining mostly labeled, the contrasting pyruvate 167 
labeling indicated that pyruvate kinase (PEP + ADP → Pyr + ATP) was forward-driven to produce 168 
ATP. 169 
Interestingly, serine, glycine, as well as other amino acids derived from pyruvate and TCA cycle 170 
intermediates were also half-labeled (Fig. 4C, Supplementary Table 3). These labeling data 171 
suggested shared usage of central metabolism, where glucose and CO2 jointly contributed to the 172 
TCA cycle (and thus non-aromatic amino acid biosynthesis). However, because glycolysis and the 173 
pentose phosphate pathway (and thus the synthesis of nucleotide ribose rings and aromatic amino 174 
acids) were driven mainly by glucose, cells incorporated more carbons from glucose. Therefore, 175 
despite the simultaneous consumption of CO2 and glucose, lack of observable net CO2 fixation was 176 
the result of cells prioritizing ATP production (and cell growth). Prioritizing ATP production 177 
involves faster glycolysis via faster glucose uptake. This substrate hierarchy favoring glucose 178 
subsequently led to excessive pyruvate decarboxylation via PFOR (Fig. 4D, Supplementary Table 179 
4) which, together with CO2-producing biosynthetic pathways (Supplementary Fig. 6), outpaced 180 
CO2 incorporation. 181 
Accelerating acetate production from CO2 by decoupling e– supply from decarboxylation 182 
Since undesirable decarboxylation is coupled to the PFOR step for e– generation from glucose, we 183 
aimed to limit the function of glucose as an e– source and to stimulate net CO2 incorporation. On the 184 
other hand, sufficient ATP is still required from glucose through pyruvate kinase to avoid slow 185 
metabolism and sustain CO2 reduction. We note that acetate production via the reductive acetyl-186 
CoA pathway does not consume ATP leading to cell maintenance (e.g., housekeeping) being the only 187 
ATP requirement for converting CO2 to acetate (Supplementary Fig. 7). Hence, we implemented 188 
glucose-limiting culture environments in a chemostat to reduce the rate of glycolysis such that it 189 
supplies the required ATP but overall decarboxylation is slowed (Fig. 5A). To compensate for the 190 
decreased e– availability, cells were provided with H2 as a carbon-free e– source that yields reducing 191 
agents without CO2 generation. In addition, low dilution rates (0.009 and 0.017 hr–1) were selected 192 
to minimize biomass formation and maximize cell residence time in the reactor.  193 
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Using this glucose doping system, productivities and yields at various fractions of electrons derived 194 
from glucose versus H2 were obtained (Fig. 5B). In this plot, we also included batch results with or 195 
without H2 in the headspace (Supplementary Table 5). Interestingly, the presence of H2 decreased 196 
glucose consumption rate, shifting carbon substrate preferences towards CO2 (Supplementary Fig. 197 
8). At steady state, acetate concentration in the effluent from the chemostat could exceed 13 g/L. 198 
With decreasing fractions of electrons from glucose, acetate production rate could be more than 80 199 
times as fast as the glucose feed rate, and the carbon yield monotonically increased to >80 g acetate 200 
produced per g glucose consumed. This high yield indicated that the overwhelming majority of 201 
acetate and biomass was derived from CO2 rather than glucose. While cell growth rates were slow 202 
in the chemostat (growth rate = dilution rate), acetate production remained fast (Fig. 5B). 203 
Importantly, we found that, at 2% of e– from glucose, glucose doping simultaneously enabled a very 204 
high yield (>50 g acetate/g glucose) and a substantial acetate productivity (>9 mmol gCDW–1 hr–1, 205 
~⅓ of the maximum observed productivity). 206 
Across the glucose+H2 energy landscape, CO2 fixation rates peaked at 52.7 mmol gCDW–1 hr–1 (2.3 g 207 
gCDW–1 hr–1) (Fig. 5C). Such high rates implied that we not only decreased CO2 generation from 208 
pyruvate decarboxylation but also increased the reductive acetyl-CoA pathway flux. Furthermore, 209 
the maximum rate occurring between the two extremes (glucose-only and H2-only) demonstrated 210 
that CO2 fixation rate is determined by a balance between reducing agents and ATP supplied via H2 211 
and glucose, respectively. Thus, by controlled glucose doping, we decoupled e– supply from 212 
decarboxylation, shifted cellular metabolism towards favoring CO2 utilization over glucose, and 213 
achieved rapid and continuous CO2 conversion into acetate. 214 
Coordination of “doped” acetogenesis and lipogenesis 215 
Coordinating acetogenesis and lipogenesis allows CO2-to-acetate-to-lipid conversion. Interestingly, 216 
the observed acetate and fatty acid productivities from glucose- and gluconate-doping (V12) 217 
exceeded not only the measured productivities with individual substrates (V1 or V2) but also the 218 
expected productivity for the two substrates combined (V1 + V2) (Fig. 6A). The expected 219 
productivity was linearly extrapolated from the combination of supplemental glucose feeding with 220 
CO2+H2 batch fermentation for acetogenesis and the combination of supplemental gluconate 221 
feeding with acetate batch fermentation for lipogenesis (Supplementary Information). 222 
We attributed the observed synergy (V12>V1+V2) to complementary substrate cofeeding. While our 223 
13C labeling experiments showed the roles of glucose and gluconate in ATP and cofactor synthesis, 224 
respectively, we sought to define the theoretical framework that illustrates the feasibility of this 225 
synergy. To this end, stoichiometric analysis of the different fates of individual substrates was 226 
combined with experimentally measured rates of single-substrate acetogenesis and lipogenesis. 227 
The maximum carbon, ATP, and electron attainable with mixed substrates were then evaluated for 228 
the two processes (Supplementary Information). We identified that the ATP and NADPH 229 
generation by glucose and gluconate doping relieved the limiting ingredients for acetate and lipid 230 
synthesis, respectively, and, in conjunction with the primary substrates, better balanced the energy 231 
and cofactor ratio requirements for reduced bioproduct synthesis (Fig. 6B). 232 
In terms of organic carbon yield, the integrated acetogenesis-lipogenesis process converted 1 g of 233 
glucose to ~13 g of lipids (0.154 g lipids/g acetate × ~82 g acetate/g glucose) by extensive CO2 234 
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utilization. Increasing mass transfer rates of gases improves H2 (and CO2) utilization efficiency, and 235 
it has been reported that ~95% of supplied H2 can be used by commercial CO2-fixing microbes30,31. 236 
By continuously converting CO2 and H2 to lipids via coordinated acetogenesis and lipogenesis, 38% 237 
of energy from H2 was stored as lipids and 14% as yeast biomass (Fig. 6C). Nearly all carbons 238 
(~99%) in lipids originated from CO2. 239 
To further explore the potential of our synergistic cofeeding approach, we applied the 240 
stoichiometric analysis to other acetyl-CoA derived products and determined the gains in 241 
productivities (Fig. 6D and Supplementary Information). Similar to the results for fatty acids, the 242 
model predicted synergy between the substrate pair in producing other reduced compounds such 243 
as polyhydroxybutyrate (PHB) and isopentenyl pyrophosphate (IPP, precursor for isoprenoids), 244 
leading to increases in productivities over the extrapolated sum (V12>V1+V2). Therefore, our 245 
substrate cofeeding strategy may stimulate conversion of CO2 into a wide array of advanced 246 
bioproducts. 247 
Discussion 248 
One of the greatest biotechnological challenges is engineering metabolism. Current engineering 249 
efforts often focus on funneling metabolic fluxes through product synthesis pathways via 250 
assembling various gene pools and knocking out competing pathways with existing genetic tools32. 251 
In addition, most processes start from sugars as the sole substrate, which inherently causes some 252 
metabolic intermediates to be out of balance and surplus components to be wasted because of the 253 
differences in chemical properties between the substrate and the product. This further necessitates 254 
the use of genetic engineering for flux rewiring in order to achieve industrially relevant production 255 
metrics. Such approaches set a limit on the choice of microbial hosts based on genetic 256 
manipulability and the existing strategies are not generalizable to all organisms. 257 
Here we presented the potential of mixed substrate cofeeding as a generalizable method and a 258 
more effective starting point for bioproduct synthesis. As the first step, we overcame the difficulties 259 
that arise due to organisms’ preferential substrate usage. Controlled continuous feeding of a 260 
preferred substrate as a metabolic dopant did not inhibit the consumption of the less favored 261 
substrate. Using this approach, we enhanced the utilization of CO2 and acetate, which are typically 262 
the end products of metabolism and therefore least preferred by organisms. This was demonstrated 263 
in both M. thermacetica and Y. lipolytica, two organisms with distinct metabolism and genetic 264 
manipulability, using various substrates (glucose and H2/CO2 as well as acetate and gluconate). 265 
Correspondingly, we expect this design to be widely applicable to other substrates and organisms. 266 
Surprisingly, substrate cofeeding synergistically enhanced product synthesis. In both cases, the 267 
total product carbon flux resulting from co-utilized substrates (V12) exceeded the sum of the 268 
individual substrate fluxes (V1 + V2). However, previous models describing substrate co-utilization 269 
have overlooked this synergistic effect11. The observation of V12>V1 + V2 could be explained by the 270 
two substrates having distinct yet complementary functions in cellular metabolism. Our 271 
stoichiometric analysis of metabolic requirements and burdens suggested that glucose and 272 
gluconate as dopant substrates could indeed complement ATP and NADPH generation, alleviating 273 
the limitations seen in acetogenesis and lipogenesis, respectively. Importantly, the observed 274 
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significant enhancements in CO2 and acetate reduction metabolism required only minor addition of 275 
“valuable” glucose and gluconate. 276 
To understand how the dopant substrates can strikingly achieve such efficiency in enhancing 277 
reductive metabolism, we also elucidated the underlying mechanisms. Tracing 13C-labeled glucose 278 
and gluconate revealed that nearly all of these supplements went into ATP and NADPH production, 279 
respectively. We identified pyruvate kinase (PEP+ADP → Pyr+ATP) in M. thermoacetica and the 280 
pentose cycle (6PG → R5P → F6P → G6P → 6PG + 2 NADPH) in Y. lipolytica to be important cofactor 281 
generating steps. In particular, activating pyruvate kinase by cofeeding glucose solved the challenge 282 
of slow CO2 fixation, which is due to ATP-limited metabolism in autotrophic fermentations31,33. 283 
Activating the pentose cycle by cofeeding gluconate solved the challenge of limited NADPH 284 
production through oxPPP in acetate-fed cells. Therefore, we rewired metabolism without genetic 285 
engineering by cofeeding dopant substrates.  286 
Finally, akin to the widespread use of dopants in the electronics industry to enhance material 287 
properties, we envision the dopant substrate cofeeding scheme becoming valuable in a wide array 288 
of biotechnological applications. Our demonstration of CO2/H2-to-acetate-to-lipids conversion at 289 
high productivity and energetic efficiency serves as an exemplary renewable energy storage 290 
strategy using substrates that do not interfere with food supply. Since acetate is closely related to 291 
acetyl-CoA, a focal point in many metabolic pathways, other acetate-based processes applying 292 
proper doping substrates could enable rapid synthesis of a wide repertoire of bioproducts such as 293 
fatty acid derived oleochemicals34 and mevalonate pathway derived natural products35. By coupling 294 
this to the glucose-doped acetogenesis, CO2 could become the initial feedstock for all subsequent 295 
acetate-driven processes, benefiting both the environment and carbon economy. Moreover, the 296 
metabolic enhancements by cofeeding superior substrates is not limited to CO2- and acetate-based 297 
fermentations. The imbalance of carbon building blocks, cofactors, and energy with respect to the 298 
desired product requirement can also be seen in many other single-substrate substrate 299 
bioconversions. In these cases, identification of complementary substrates and implementation of 300 
controlled dopant substrate cofeeding would optimally coordinate pathway usage for superior 301 
biosynthesis. Consequently, substrates previously considered infeasible for industrial bioprocesses 302 
due to limited productivity may become well-suited as economically and technologically viable 303 
feedstocks36. 304 
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Figures314 
 315 
Figure 1. Continuous glucose cofeeding relieves repression of acetate in Y. lipolytica. (A) 316 
Acetate can efficiently support acetyl-CoA and ATP generation through the TCA cycle but not 317 
NADPH generation, which requires many enzymatic steps and ATP. Glucose, on the other hand, can 318 
produce NADPH more directly through oxPPP. (B) Since glucose batch feeding suppresses acetate 319 
consumption, glucose was continuously supplemented in small quantities to the acetate culture. (C) 320 
Despite the continuous feeding of glucose, its concentration in the reactor remained at 0 and 321 
acetate concentration decreased. Thus, the fed-batch system enabled simultaneous consumption of 322 
acetate and glucose. (D) Biomass and (E) lipid production was faster and higher with glucose-323 
“doping” compared to the acetate-only control. 324 
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Figure 2. Cofeeding substrates near oxidative pentose phosphate pathway accelerates cell 326 
growth and lipogenesis from acetate. (A) Glucose, fructose, glycerol, and gluconate enter central 327 
carbon metabolism through upper glycolysis and PPP. (B) Supplementation of these four substrates 328 
accounted for ~5% of the total carbon consumed by the cells and the primary carbon source was 329 
acetate. (C) Specific growth rates nearly doubled with substrate cofeeding compared to the acetate-330 
only control. (D) Growth phase (nitrogen-replete) specific lipid productivity nearly doubled with 331 
substrate cofeeding. (E) Lipogenic phase (nitrogen-depleted) specific lipid productivity was mildly 332 
enhanced by glucose, fructose, or glycerol supplementation. Gluconate-“doping” significantly 333 
outperformed the other conditions. 334 
  335 
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Figure 3. Gluconate generates NADPH via the pentose cycle. (A) Tracing carbons from [U-337 
13C6]gluconate revealed partitioned usage of metabolism. The heavy 13C of gluconate remained 338 
mainly in upper glycolysis and PPP. Acetyl-CoA and TCA intermediates were completely unlabeled, 339 
indicating exclusive contribution from acetate. (B) Metabolic flux analysis via isotope mass 340 
balancing revealed the cyclic reaction sequence generating NADPH. The “pentose cycle” consisted 341 
of the NADPH-producing oxPPP, transketolase, transaldolase, and phosphoglucose isomerase. Flux 342 
values are in mmol gCDW–1 hr–1. 343 
  344 
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 345 
Figure 4. Glucose generates ATP for CO2 fixation but leads to decarboxylation in M. 346 
thermoacetica. (A) The reductive acetyl-CoA pathway consists of the carbonyl and methyl 347 
branches for conversion of CO2 into acetyl group. The methyl branch requires ATP. (B) Analysis of 348 
carbon input and output in batch cofeeding of M. thermoacetica with glucose and CO2 revealed the 349 
preferential use of glucose. (C) Batch cofeeding [U-13C6]glucose and CO2 revealed the simultaneous 350 
use of glucose and CO2. Glucose carbons contributed mainly to glycolysis and PPP while partially to 351 
TCA cycle. A substantial fraction of TCA carbons was traced to CO2. (D) Despite simultaneous 352 
utilization of CO2, preferred glucose use led to undesirable decarboxylation outpacing CO2 uptake. 353 
Flux values are in mmol gCDW–1 hr–1 of acetyl-CoA. 354 
  355 
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 356 
Figure 5. Continuous glucose cofeeding accelerates acetogenesis from CO2 fixation at the 357 
autotrophic limit. (A) Since glucose batch feeding leads to undesirable decarboxylation, glucose 358 
was continuously supplemented in small quantities to gas-fermenting M. thermoacetica culture. 359 
(B,C) Acetate productivity, yield, and CO2 fixation rate at varying ratios of electrons (e–) derived 360 
from H2 and glucose. The plots include both batch and chemostat data (Supplementary Table 5). 361 
(B) Acetate productivity peaked when 91% of e– were derived from H2 and 9% glucose. On the 362 
other hand, carbon yield (acetate produced per glucose consumed) increased with increasing 363 
fraction of electrons from H2. (C) CO2 fixation rate peaked when 9% of e– were derived from glucose 364 
and remained high near the autotrophic limit. 365 
  366 
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Figure 6. Synergy and coordination of substrate cofeeding accelerate the conversion of CO2 368 
and H2 into lipids. (A) Glucose- and gluconate-doping resulted in synergy that accelerated 369 
acetogenesis and lipogenesis beyond the linear extrapolation of additional carbon supplement. (B) 370 
The maximum CO2 fixation and fatty acid production rates were attained by cofeeding glucose and 371 
gluconate in limiting quantities. Stoichiometric analysis of metabolic requirements and burdens 372 
revealed the key role of glucose and gluconate in generating ATP and NADPH. The dashed arrows 373 
denote negligible contributions. (C) In terms of energy efficiency, 95% of H2 energy can be stored as 374 
acetate by M. thermoacetica and 55% of acetate energy can be stored as lipids by Y. lipolytica. 375 
Coordination of acetogenesis and lipogenesis enabled storage of 38% of H2 energy as lipids and 376 
14% as biomass. (D) The cofeeding approach can also be applied to synthesizing other products 377 
with predicted synergistic productivity that exceeds the sum of individual-substrate productivities. 378 
  379 
15 
 
References 380 
1 Ledesma-Amaro, R. & Nicaud, J. M. Metabolic Engineering for Expanding the Substrate 381 
Range of Yarrowia lipolytica. Trends Biotechnol 34, 798-809, 382 
doi:10.1016/j.tibtech.2016.04.010 (2016). 383 
2 Atsumi, S., Hanai, T. & Liao, J. C. Non-fermentative pathways for synthesis of branched-384 
chain higher alcohols as biofuels. Nature 451, 86, doi:10.1038/nature06450 (2008). 385 
3 Xue, Z. et al. Production of omega-3 eicosapentaenoic acid by metabolic engineering of 386 
Yarrowia lipolytica. Nat Biotechnol 31, 734-740, doi:10.1038/nbt.2622 (2013). 387 
4 Qiao, K. J., Wasylenko, T. M., Zhou, K., Xu, P. & Stephanopoulos, G. Lipid production 388 
in Yarrowia lipolytica is maximized by engineering cytosolic redox metabolism. Nature 389 
biotechnology 35, 173-177, doi:10.1038/nbt.3763 (2017). 390 
5 Kita, A. et al. Development of genetic transformation and heterologous expression 391 
system in carboxydotrophic thermophilic acetogen Moorella thermoacetica. J Biosci 392 
Bioeng 115, 347-352, doi:10.1016/j.jbiosc.2012.10.013 (2013). 393 
6 Monod, J. Recherches sur la croissance des cultures bacteriennes.  (1942). 394 
7 Aristilde, L., Lewis, I. A., Park, J. O. & Rabinowitz, J. D. Hierarchy in Pentose Sugar 395 
Metabolism in Clostridium Acetobutylicum. Appl Environ Microbiol, 396 
doi:10.1128/AEM.03199-14 (2014). 397 
8 Goerke, B. & Stulke, J. Carbon catabolite repression in bacteria: many ways to make the 398 
most out of nutrients. Nat Rev Microbiol 6, 613-624, doi:Doi 10.1038/Nrmicro1932 399 
(2008). 400 
9 Bren, A. et al. Glucose becomes one of the worst carbon sources for E.coli on poor 401 
nitrogen sources due to suboptimal levels of cAMP. Sci Rep 6, 24834, 402 
doi:10.1038/srep24834 (2016). 403 
10 Joshua, C. J., Dahl, R., Benke, P. I. & Keasling, J. D. Absence of diauxie during 404 
simultaneous utilization of glucose and Xylose by Sulfolobus acidocaldarius. J Bacteriol 405 
193, 1293-1301, doi:10.1128/JB.01219-10 (2011). 406 
11 Hermsen, R., Okano, H., You, C., Werner, N. & Hwa, T. A growth-rate composition 407 
formula for the growth of E.coli on co-utilized carbon substrates. Mol Syst Biol 11, 801, 408 
doi:10.15252/msb.20145537 (2015). 409 
12 Kanno, M., Carroll, A. L. & Atsumi, S. Global metabolic rewiring for improved CO2 410 
fixation and chemical production in cyanobacteria. Nature communications 8, 411 
doi:10.1038/Ncomms14724 (2017). 412 
13 Martinez, K. et al. Coutilization of glucose and glycerol enhances the production of 413 
aromatic compounds in an Escherichia coli strain lacking the phosphoenolpyruvate: 414 
carbohydrate phosphotransferase system. Microb Cell Fact 7, 1, doi:10.1186/1475-2859-415 
7-1 (2008). 416 
14 Meyer, F. et al. Methanol-essential growth of Escherichia coli. Nature communications 9, 417 
doi:10.1038/S41467-018-03937-Y (2018). 418 
15 Garcia Sanchez, R. et al. Improved xylose and arabinose utilization by an industrial 419 
recombinant Saccharomyces cerevisiae strain using evolutionary engineering. Biotechnol 420 
Biofuels 3, 13, doi:10.1186/1754-6834-3-13 (2010). 421 
16 Kim, S. M. et al. Simultaneous utilization of glucose and xylose via novel mechanisms in 422 
engineered Escherichia coli. Metab Eng 30, 141-148, doi:10.1016/j.ymben.2015.05.002 423 
(2015). 424 
16 
 
17 Jones, S. W. et al. CO2 fixation by anaerobic non-photosynthetic mixotrophy for 425 
improved carbon conversion. Nat Commun 7, 12800, doi:10.1038/ncomms12800 (2016). 426 
18 Bowes, G., Hageman, R. H. & Ogren, W. L. Light Saturation, Photosynthesis Rate, Rudp 427 
Carboxylase Activity, and Specific Leaf Weight in Soybeans Grown under Different 428 
Light Intensities. Crop Sci 12, 77-& (1972). 429 
19 Xu, J., Liu, N., Qiao, K., Vogg, S. & Stephanopoulos, G. Application of metabolic 430 
controls for the maximization of lipid production in semicontinuous fermentation. Proc 431 
Natl Acad Sci U S A 114, E5308-E5316, doi:10.1073/pnas.1703321114 (2017). 432 
20 Ratledge, C. & Wynn, J. P. The biochemistry and molecular biology of lipid 433 
accumulation in oleaginous microorganisms. Advances in applied microbiology 51, 1-51 434 
(2002). 435 
21 Qiao, K. et al. Engineering lipid overproduction in the oleaginous yeast Yarrowia 436 
lipolytica. Metab Eng 29, 56-65, doi:10.1016/j.ymben.2015.02.005 (2015). 437 
22 Fontanille, P., Kumar, V., Christophe, G., Nouaille, R. & Larroche, C. Bioconversion of 438 
volatile fatty acids into lipids by the oleaginous yeast Yarrowia lipolytica. Bioresource 439 
Technology 114, 443-449, doi:https://doi.org/10.1016/j.biortech.2012.02.091 (2012). 440 
23 Liu, N., Qiao, K. & Stephanopoulos, G. (13)C Metabolic Flux Analysis of acetate 441 
conversion to lipids by Yarrowia lipolytica. Metab Eng 38, 86-97, 442 
doi:10.1016/j.ymben.2016.06.006 (2016). 443 
24 Gancedo, J. M. Carbon catabolite repression in yeast. Eur J Biochem 206, 297-313 444 
(1992). 445 
25 Casazza, J. P. & Veech, R. L. The Interdependence of Glycolytic and Pentose Cycle 446 
Intermediates in Ad-Libitum Fed Rats. J Biol Chem 261, 690-698 (1986). 447 
26 Ragsdale, S. W. & Pierce, E. Acetogenesis and the Wood-Ljungdahl pathway of CO(2) 448 
fixation. Biochimica et biophysica acta 1784, 1873-1898, 449 
doi:10.1016/j.bbapap.2008.08.012 (2008). 450 
27 Mall, A. et al. Reversibility of citrate synthase allows autotrophic growth of a 451 
thermophilic bacterium. Science 359, 563-567, doi:10.1126/science.aao2410 (2018). 452 
28 Nunoura, T. et al. A primordial and reversible TCA cycle in a facultatively 453 
chemolithoautotrophic thermophile. Science 359, 559-563, doi:10.1126/science.aao3407 454 
(2018). 455 
29 Schuchmann, K. & Muller, V. Autotrophy at the thermodynamic limit of life: a model for 456 
energy conservation in acetogenic bacteria. Nat Rev Microbiol 12, 809-821, 457 
doi:10.1038/nrmicro3365 (2014). 458 
30 Daniell, J., Köpke, M. & Simpson, S. Commercial Biomass Syngas Fermentation. 459 
Energies 5, 5372 (2012). 460 
31 Hu, P., Rismani-Yazdi, H. & Stephanopoulos, G. Anaerobic CO2 fixation by the 461 
acetogenic bacterium Moorella thermoacetica. AIChE Journal 59, 3176-3183, 462 
doi:10.1002/aic.14127 (2013). 463 
32 Blazeck, J. et al. Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid 464 
and biofuel production. Nat Commun 5, 3131, doi:10.1038/ncomms4131 (2014). 465 
33 Daniel, S. L., Hsu, T., Dean, S. I. & Drake, H. L. Characterization of the H2- and CO-466 
dependent chemolithotrophic potentials of the acetogens Clostridium thermoaceticum and 467 
Acetogenium kivui. J Bacteriol 172, 4464-4471 (1990). 468 
17 
 
34 Ledesma-Amaro, R., Dulermo, R., Niehus, X. & Nicaud, J. M. Combining metabolic 469 
engineering and process optimization to improve production and secretion of fatty acids. 470 
Metab Eng 38, 38-46, doi:10.1016/j.ymben.2016.06.004 (2016). 471 
35 Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D. & Keasling, J. D. 472 
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. 473 
Nature biotechnology 21, 796-802, doi:10.1038/nbt833 (2003). 474 
36 Haynes, C. A. & Gonzalez, R. Rethinking biological activation of methane and 475 
conversion to liquid fuels. Nat Chem Biol 10, 331-339, doi:10.1038/nchembio.1509 476 
(2014). 477 
 478 
 479 
 480 
Methods 481 
Strains and culture conditions 482 
Yarrowia lipolytica strains based on the ACCDGA strain (MTYL065)37 were pre-cultured at 30 °C in 483 
14 mL test tubes containing YPD media (20 g/L glucose, 20 g/L peptone, 10 g/L yeast extract). After 484 
24 hr, 1 mL culture was transferred to a shake flask containing 40 mL of acetate media (50 g/L 485 
sodium acetate, 1.7 g/L YNB-AA-AS, and 1.34 g/L ammonium sulfate). The shake flask culture was 486 
carried out for 24 hr to adapt the cells to acetate. Afterwards, the cells were pelleted at 18,000 g for 487 
5 min, washed once with acetate media, and used for inoculation at an initial OD600 of 0.05 for all Y. 488 
lipolytica experiments.  489 
Mixed substrate batch cultures were carried out in shake flasks with 40 mL of acetate media except 490 
that 6 mol% of the total carbon from acetate was replaced with the supplemental substrate 491 
(glucose, fructose, glycerol, or gluconate). Continuous fed-batch supplementation cultures were 492 
carried out in 250 mL bioreactors (Applikon Biotechnology) with 150 mL working volume. Acetate 493 
media was used under batch conditions while the supplemented substrate was continuously fed at 494 
a rate of 0.13 mmol C/hr. For the acetate-only control case, the supplemented substrate was 495 
replaced with acetate and fed at the same rate to ensure that cells had equal amounts of carbon 496 
substrates throughout all conditions.  All bioreactor cultures were carried out at 30 °C, pH 7.0 497 
(controlled with 10 wt% sulfuric acid), and 0.2 LPM air sparging. The dissolved oxygen levels were 498 
controlled at 20% during the growth phase and ~2% during the lipogenic phase for optimal lipid 499 
production and minimal citrate excretion4. For gluconate 13C tracing experiments, natural gluconate 500 
in the supplementation feed stream was replaced with [U-13C6]gluconate (99%, Cambridge Isotope 501 
Laboratories). 502 
In all Y. lipolytica experiments having gluconate as a substrate, an ACCDGA strain overexpressing its 503 
native gluconate kinase (glucK) under the TEFin promoter was used. The expression of TEFin-glucK 504 
was performed through genome integration. This was to ensure that gluconate uptake and 505 
incorporation into central carbon metabolism was not inhibited by inadequate levels of the kinase. 506 
All other experiments were performed using the same ACCDGA strain with an empty control vector 507 
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integrated into the genome. Overexpressing gluconate kinase did not have any appreciable effects 508 
on the strain’s capability to produce lipids on acetate, as shown in Supplementary Fig. 9. 509 
Moorella thermoacetica (ATCC 39073 and 49707) were cultured in balch-type tubes containing 510 
culture medium with 8 g/L glucose, 7.5 g/L NaHCO3, 7 g/L KH2PO4, 5.5 g/L K2HPO4, 2 g/L 511 
(NH4)2SO4, 0.5 g/L MgSO4 • 7H2O, 0.3 g/L cysteine, 0.02 g/L CaCl2 • 2H2O, 1% (v/v) trace minerals 512 
(ATCC MD-TMS), and 1% (v/v) vitamins (ATCC MD-VS) at 55 °C pH 6.8. Cysteine scavenged 513 
residual dissolved oxygen in the medium38. The headspace was pressurized to either 170 kPa with 514 
CO2 or 240 kPa with 80:20 H2/CO2. For 13C tracing experiments, natural glucose was replaced with 515 
[U-13C6]glucose (99%, Cambridge Isotope Laboratories) and the headspace was pressurized to 170 516 
kPa with natural CO2. The balch-tube cultures were incubated inside a strictly anoxic glovebox with 517 
magnetic stirring. 518 
For bioreactor experiments, M. thermoacetica (ATCC 49707) was cultured in a strictly anoxic vessel 519 
with pH and temperature control set to 6.6 (using 10M sodium hydroxide) and 55°C. Low glucose 520 
but otherwise identical culture media were fed as follows (media glucose concentrations and media 521 
feed rates): 0.25 g/L at 11.5 mL/hr; 0.25 g/L at 9.1 mL/hr; 0.25 g/L at 6.9 mL/hr; 0.25 g/L at 4.3 522 
mL/hr; 0.25 g/L at 2.3 mL/hr; 0.25 g/L at 1.2 mL/hr; and  0.13 g/L at 1.2 mL/hr. The rate of 523 
effluent was the same to keep the culture volume constant at 135 mL. H2 and CO2 were mixed at 524 
60:40 and sparged into the culture at 200 mL/min. The headspace pressure was maintained at 130 525 
kPa. All the data and conditions are shown in Supplementary Table 5. 526 
Metabolite extraction and measurement 527 
To extract metabolites, Y. lipolytica cells were collected during exponential and lipogenic phases. 528 
Cells were filtered on 0.45 µm nylon membrane filters and immediately transferred to a precooled 529 
40:40:20 acetonitrile/methanol/water solution. After 20 minutes at -20°C, the filters were washed, 530 
and extracts were moved to Eppendorf tubes. The samples were then centrifuged for five minutes 531 
and the supernatants were dried under nitrogen. 532 
In mid-exponential phase, the M. thermoacetica cultures were collected from balch-type tubes using 533 
syringes inside the anaerobic glovebox. Immediately after, cellular metabolism was quenched and 534 
metabolites were extracted by quickly transferring filtered cells (on 0.2 µm nylon membrane filter) 535 
to plates containing precooled 80% acetonitrile on ice39. After 20 minutes at 4°C, the membrane 536 
filters were washed, and the metabolite extracts were moved to Eppendorf tubes. The supernatants 537 
were obtained after five minutes of centrifugation and lyophilized. 538 
Dried samples were resuspended in HPLC-grade water for LC-MS analysis. These samples were 539 
analyzed on a Dionex UltiMate 3000 UPLC system (Thermo) with a ZIC-pHILIC (5 µm polymer 540 
particle) 150 × 2.1 mm column (EMD Millipore) coupled to a QExactive orbitrap mass spectrometer 541 
(Thermo) by electrospray ionization. With 20 mM ammonium carbonate, 0.1% ammonium 542 
hydroxide as solvent A and acetonitrile as solvent B, the chromatographic gradient was run at a 543 
flow rate of 0.150 mL/min as a linear gradient from 80% B to 20% B between 0 and 20 mins, a 544 
linear gradient from 20% B to 80% B between 20 and 20.5 mins, and 80% B held from 20.5 to 28 545 
mins. The column and autosampler tray temperature were at 25 °C and 4 °C. The mass 546 
spectrometer was operated in polarity switching mode scanning a range of 70-1,000 m/z. The 547 
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resolving power was set to 70,000 for 13C labeling experiments. With retention times determined 548 
by authenticated standards, resulting mass spectra and chromatograms were identified and 549 
processed using MAVEN software40. To obtain labeling information of cellular bicarbonate and 550 
acetate, the labeling of carbamoyl group was obtained by comparing (i.e., computing the inverse 551 
Cauchy product) citrulline to ornithine, and the labeling of acetyl group was obtained by comparing 552 
N-acetyl-glutamate to glutamate. 553 
Substrate uptake and product secretion measurement 554 
For Y. lipolytica, 1 mL of culture was taken at each time point for media and cell dry weight (CDW) 555 
analysis. The cells were centrifuged at 18,000 g for 10 min and the supernatant was subsequently 556 
extracted, filtered (0.2 µm syringe filters), and analyzed on a high-performance liquid 557 
chromatography (HPLC).  The cell pellet was then wash once with 1 mL water to remove residual 558 
media components and dried in a 60 °C oven until its mass remains unchanged. This mass was 559 
taken to be the CDW per mL of culture. As for lipids, a small volume was extracted from the culture 560 
such that it contains ~1 mg of CDW. The supernatant was discarded after centrifugation at 18,000g 561 
for 10 min. 100 μL of an internal standard containing 2 mg/mL methyl tridecanoate (Sigma-562 
Aldrich) and 2 mg/mL glyceryl triheptadecanoate (Sigma-Aldrich) in hexane was added to each 563 
sample. Transesterification was then carried out in 500 μL 0.5 N sodium methoxide solutions with 564 
continuous vortexing at 1200 rpm for 60 min. Afterwards, 40 μL of 98% sulfuric acid was added to 565 
neutralize the pH and 500 μL of hexane was used for extraction. Additional vortexing at 1200 rpm 566 
for 30 min was carried out and centrifugation at 6,000 g for 1 min was performed to remove 567 
cellular debris. The top hexane layer was used for analysis on a GC-FID system. All Y. lipolytica 568 
specific rate data were normalized to the lipid-free CDW, which was the difference between the 569 
measured CDW and the lipid titer. 570 
For media analysis in M. thermoacetica cultures, small aliquots of the cultures were collected with 571 
syringes inside the anaerobic glovebox over their exponential phase. Filtered media samples (0.2 572 
µm syringe filters) were analyzed by YSI biochemistry analyzer for glucose and by HPLC for acetate 573 
and formate along with other potential products (e.g., lactate and ethanol). Culture density was 574 
measured by spectrophotometry (0.45 gCDW L–1 OD660–1) at the time of sampling. The rates of 575 
substrate uptake and product secretion were determined using the rates at which substrates, 576 
products, culture density change over time. The carbon output rate for biomass was determined 577 
using growth rate and elemental biomass composition of CH2.08O0.53N0.24 41. The net CO2 fixation 578 
rates were calculated based on the measured acetate and biomass carbon production rates less the 579 
corresponding measured glucose carbon consumption rates. The fraction of electrons derived from 580 
H2 was inferred from the fraction of acetate and biomass carbons generated from net CO2 fixation 581 
since the average oxidation state of acetate and biomass carbons is nearly the same as that of 582 
glucose. 583 
For HPLC, 10 μL sample was injected into an Agilent 1200 High-Performance Liquid 584 
Chromatography system coupled to a G1362 Refractive Index Detector (Agilent Technologies). A 585 
Bio-Rad HPX-87H column was used for separation with 14 mM sulfuric acid as the mobile phase 586 
flowing at 0.7 mL/min. For GC-FID, 1 μL of sample was injected at a split ratio of 50:1 into an 587 
Agilent 7890B GC-FID system coupled to a J&W HP-INNOWax capillary column (Agilent 588 
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Technologies). The column was held at a constant temperature of 200 °C with helium as the carrier 589 
gas (1.5 mL/min). The injection and FID temperatures were set to 260 °C. 590 
Headspace gas measurement 591 
After collecting the M. thermoacetica cultures from balch-type tubes inside the anaerobic glovebox 592 
for intracellular and extracellular metabolite analysis, the empty balch-type tubes containing only 593 
the headspace gas were stored at 4 °C until gas chromatography-mass spectrometry (GC-MS) 594 
analysis. To measure CO2 isotope labeling, 100 µl of headspace sample was collected from each tube 595 
with a gastight syringe and injected in a multimode inlet, which was maintained at 180 °C, with a 596 
split of 10. Samples were analyzed on a 7890A GC system with a 60 m GS-GasPro (0.320 mm 597 
diameter) column coupled with a 5975C quadrupole mass spectrometer (Agilent). The oven was 598 
kept at 90 °C for 3 minutes before heating to 260 °C at 45 °C/min and held at 260 °C for 1 minute. 599 
Flux balance analysis and isotope tracing flux analysis 600 
M. thermoacetica model based on the published genome-scale metabolic reconstruction42 was 601 
employed for constraint-based flux analysis (see Supplementary Information). Among the 602 
feasible metabolic flux distributions that satisfy steady-state mass balance and nutrient availability 603 
constraints, optimal solutions that maximize/minimize objective functions were obtained using the 604 
COBRA toolbox and a Gurobi solver43. To determine CO2 utilization capability, the objective was to 605 
maximize CO2 consumption, or equivalently, minimize CO2 production. To determine the growth 606 
potential using H2 as the energy source, the objective was to maximize biomass production (i.e., cell 607 
growth). Substrate uptake and product secretion rate constraints were selected based on 608 
experimental or previously reported values. 609 
To determine flux distributions, isotopomer mass balance constraints were also imposed based on 610 
the 13C labeling results. For this purpose, the metabolic networks including glycolysis and PPP for Y. 611 
lipolytica as well as lower glycolysis, the TCA cycle, anaplerosis, the reductive acetyl-CoA pathway 612 
and the serine/glycine pathway for M. thermoacetica were constructed with carbon atom mapping. 613 
The labeling of following metabolites were simulated by the elementary metabolite unit (EMU) 614 
framework44: for Y. lipolytica, G6P, F6P, 3PG, S7P, 6PG, R5P, PEP, and Pyr (Supplementary Table 615 
1); for M. thermoacetica, 3PG, PEP, Ala, acetyl-CoA, Ser, Gly, Asp, Glu, and CO2 (Supplementary 616 
Table 3). 617 
The flux distribution that best simulated the metabolite labeling and uptake-secretion rates was 618 
found by minimizing the variance weighted-sum of squared residuals (SSR) between simulation 619 
and experiment: 620 
min௩   ෍ ቆ
݅ݏ݋௘௫௣ − ݅ݏ݋(ݒ)
ݏ௜௦௢ ቇ
ଶ
+ ෍ ൬ݒ௘௫௣ − ݒݏ௩ ൰
ଶ
 
ݒ and ݅ݏ݋(ݒ) denote in vector form the metabolic flux distribution and the simulated 13C labeling of 621 
metabolites as a function of ݒ. ݒ௘௫௣ and ݅ݏ݋௘௫௣ denote measured fluxes and measured metabolite 622 
labeling; ݏ௩and ݏ௜௦௢, their measurement standard deviation. The 95% confidence interval for each 623 
best fit flux was obtained by searching for the minimum and maximum flux values that increase the 624 
minimum SSR by less than the χ2 cutoff (1 degree of freedom) of 3.84.45 625 
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Code availability 626 
The code for metabolic flux and free energy analysis is available on the GitHub public repository: 627 
https://github.com/jopark/moorella_yarrowia 628 
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